DESCRIPTION:
This fourth edition of the Oxford Textbook of Clinical Nephrology builds on the success and international reputation of the publication as an important resource for the practising clinician in the field. It provides practical, scholarly, and evidence-based coverage of the full spectrum of clinical nephrology, written by a global faculty of experts.
The most relevant and important reference to clinical nephrology, this is an authoritative and comprehensive textbook combining the clinical aspects of renal disease essential to daily clinical practice with extensive information about the underlying basic science and current evidence available. Each section of the textbook has been critically and comprehensively edited under the auspices of a leading expert in the field.
This new edition has been significantly expanded and reapportioned to reflect developments and new approaches to topics, and includes treatment algorithms to aid and enhance patient care where possible. The fourth edition offers increased focus on the medical aspects of transplantation, HIV-associated renal disease, and infection and renal disease, alongside entirely new sections on genetic topics and clinical and physiological aspects of fluid/electrolyte and tubular disorders. The emphasis throughout is on marrying advances in scientific research with clinical management.
Richly illustrated throughout in full colour, this is a truly modern and attractive edition which reinforces the Oxford Textbook of Clinical Nephrology""s position as an indispensable reference work of consistent quality and reliability. Enriched and refined by careful revision, this new edition continues the tradition of excellence.
This print edition of The Oxford Textbook of Clinical Nephrology comes with a year""s access to the online version on Oxford Medicine Online. By activating your unique access code, you can read and annotate the full text online, follow links from the references to primary research materials, and view, enlarge and download all the figures and tables. Oxford Medicine Online is mobile optimized for access when and where you need it.
CONTENTS:
VOLUME 1
Part 1: Assessment of the patient with renal disease
1: Aminu K. Bello, Marcello Tonelli, and Kitty J. Jager: Epidemiology of kidney disease
2: Chris Winearls: Clinical assessment of the patient with renal disease
3: Chris Winearls: Presentations of renal disease
4: Chris Winearls: Kidney disease focused history taking
5: Chris Winearls: Kidney disease focused features on examination
6: Walter P. Mutter: Urinalysis
7: Walter P. Mutter: Assessment of renal function
8: Walter P. Mutter: Tubular function
9: Michael Weston: Renal radiology: overview
10: Jeannette Kathrin and Peter Howells: Ionising radiation and radiation protection
11: Akira Kawashima and Andrew J. LeRoy: Plain radiography, excretion radiography, and contrast radiography
12: Steven Kennish: Intervention
13: Toby Wells and Simon Freeman: Ultrasound
14: Eugene Teoh and Michael Weston: Computed tomography
15: Kazuhiro Kitajima, Akira Kawashima. and James F Glockner: Magnetic Resonance Imaging
16: Ramya Dhandapani and Sobhan Vinjamuri: Radioisotopes in diagnostic imaging in nephrology
17: Jo H.M. Berden and Jack Wetzels: Immunological investigation of the patient with renal disease
18: Ian Roberts, Phil Mason and Agnes Fogo: The renal biopsy
19: Richard Haynes, Martin J Landry, William G Herrington, and Colin Baigent: Clinical trials- how and why in nephrology
Part 2: The patient with fluid, electrolyte, and renal tubular disorders
20: Matthew A. Bailey: An overview of tubular function
21: Laurent Schild: Sodium transport and balance: A key role for the distal nephron
22: David Marples and Soren Neilson: Water homeostasis
23: Alain Doucet and Gilles Crambert: Potassium homeostasis
24: Carsten Wagner and Olivier Devuyst: Renal acid-base homeostasis
25: Heini Murer, Juerg Biber, and Carsten Wagner: Phosphate homeostasis
26: Francesco Trepiccione and Gianni Capasso: Calcium homeostasis
27: Pascal Houillier: Magnesium homeostasis
28: Ewout Hoorn and Bob Zietse: Approach to the patient with hyponatraemia
29: Bob Zietse: Approach to the patient with hypernatraemia
30: Jean-Marie Krzesinski and Eric P. Cohen: Approach to the patient with oedema
31: Detlef Bockenhauer and Robert Kleta: Approach to the patient with salt-wasting
32: Daniel Bichet: Approach to the patient with polyuria
33: David Ellison and Arohan R. Subramanya: Clinical use of diuretics
34: Charles Wingo and I. David Weiner: Approach to the patient with hypo-/hyperkalaemia
35: Mitch Halperin and Kamel Kamel: Approach to the patient with metabolic acidosis or alkalosis
36: Stephen Walsh: Approach to the patient with renal tubular acidosis
37: Dennis Jose Joseph and Theresa A. Guise: Approach to the patient with hypercalcaemia
38: Agnes Linglart and Anne-Sophie Lambert: Approach to the patient with hypocalcaemia
39: Judith Blaine, Hector Giral-Arnal, Sabina Jelen, and Moshe Levi: Approach to the patient with hypo-/hyperphosphataemia
40: Martin Konrad and Karl Peter Schlingmann: Approach to the patient with hypomagnesaemia
41: Detlef Bockenhauer and Robert Kleta: Approach to the patient with renal Fanconi syndrome, glycosuria or aminoaciduria
Part 3: The patient with glomerular disease
42: Alexander Woywodt and Diana Chiu: The glomerulus and the concept of glomerulonephritis
43: Marlies Elger and Wilhelm Kriz: The renal glomerulus - the structural basis of ultrafiltration
44: Jean-Claude Dussaule, Martin Flamant, and Christos Chatziantoniou: Function of the normal glomerulus
45: Neil Turner: Mechanisms of glomerular injury: overview
46: John Neary and Neil Turner: The patient with haematuria
47: John Neary: Loin pain haematuria syndrome
48: John Neary and Neil Turner: Nutcracker syndrome and phenomenon
49: Neil Turner: Exercise-related pseudonephritis
50: Neil Turner and Stewart Cameron: Proteinuria
51: Neil Turner: Postural proteinuria (Benign orthostatic proteinuria)
52: Premil Rajakrishna, Stewart Cameron and Neil Turner: Nephrotic syndrome
53: Neil Turner and Premil Rajakrishna: Pathophysiology of oedema in nephrotic syndrome
54: Patrick Niaudet and Alain Meyrier: Idiopathic nephrotic syndrome: overview
55: Patrick Niaudet and Alain Meyrier: Minimal change disease: clinical features and diagnosis
56: Patrick Niaudet and Alain Meyrier: Minimal change disease: treatment and outcome
57: Patrick Niaudet and Alain Meyrier: Primary focal segmental glomerulosclerosis (FSGS): Clinical features and diagnosis
58: Patrick Niaudet and Alain Meyrier: Primary focal segmental glomerulosclerosis (FSGS): Treatment and outcome
59: Patrick Niaudet and Alain Meyrier: Pathogenesis of proteinuria in minimal change disease and FSGS
60: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: overview
61: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: clinical features and diagnosis
62: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: treatment and outcome
63: Daniel Cattran and Heather Reich: Secondary membranous glomerulonephritis
64: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: pathogenesis
65: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: overview
66: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: clinical features
67: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: diagnosis
68: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: treatment and outcome
69: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: pathogenesis
70: Neil Turner: Crescentic (rapidly progressive) glomerulonephritis
71: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: overview
72: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: clinical features and diagnosis
73: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: treatment and outcome
74: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Antiglomerular basement membrane disease: pathogenesis
75: Neil Turner: Alport post-transplant antiglomerular basement membrane disease
76: Bernardo Rodriguez-Iturbe and Mark Haas: Post-infectious glomerulonephritis: overview
77: Bernardo Rodriguez-Iturbe and Mark Haas: Post streptococcal glomerulonephritis
78: Bernardo Rodriguez-Iturbe and Mark Haas: Immunoglobulin A dominant post-infectious glomerulonephritis
79: Bernardo Rodriguez-Iturbe and Mark Haas: Glomerulonephritis associated with endocarditis, deep-seated infections and shunt nephritis
80: T. Cook and Daniel Gale: Membranoproliferative glomerulonephritis and C3 glomerulopathy
81: Stephen Korbet, Melvin M.Schwartz, and Edmund J. Lewis: Fibrillary and immunotactoid glomerulopathy
82: Alexander Woywodt and Diana Chiu: Drug induced and toxic glomerulopathies
Part 4: The patient with interstitial disease
83: Richard Baker and B.Chir: Acute tubulointerstitial nephritis: overview
84: Hassan Izzedine and Victor Gueutin: Drug-induced acute tubulointerstitial nephritis
85: Gregory L. Braden and Benjamin J. Freda: Other toxic acute tubulointerstitial nephritis
86: Adalbert Schiller, Adrian Covic, and Liviu Segall: Chronic tubulointerstitial nephritis: overview
87: Hassan Izzedine and Victor Gueutin: Drug-induced chronic tubulointerstitial nephritis
88: Patrick C D""Haese, Benjamin Vervaet, and A Verhulst: Heavy metals-induced tubulointerstitial nephritis
89: Refik Gökmen and Graham Lord: Aristolochic acid nephropathy caused by ingestion of herbal medicinal products
90: Milan Radovic and Adalbert Schiller: Balkan endemic nephropathy
91: Lisa Phipps and David C. Harris: Radiation nephropathy
92: D. H. Kang and M. Kanbay: Urate nephropathy
93: Liviu Segall and Adrian Covic: Immune-mediated tubulointerstitial nephritis
Part 5: The patient with reduced renal function
94: Ashish Upadhyay, Lesley Inker, and Andrew Levey: Chronic kidney disease: definition, classification, and approach to management
95: Morgan Grams and Josef Coresh: Chronic kidney disease in the developed world
96: LuXia Zhang and Haiyan Wang: Chronic kidney disease in developing countries
97: M. Beaulieu, C. Weber, N. Zalunardo and Adeera Levin: Chronic kidney disease long-term outcomes: progression, death, cardiovascular disease, infections, and hospitalizations
98: David Goldsmith: Cardiovascular disease and chronic kidney disease: overview
99: Charles Ferro and Khai Ping Ng: Recommendations for management of high renal risk chronic kidney disease
100: Teena Tandon and Rajiv Agarwal: Hypertension as a cause of chronic kidney disease: what is the evidence?
101: Juan Jesus Carrero, Xu Hong, and Bengt Lindholm: Diet and the progression of chronic kidney disease
102: Alan Jardine and Rajan Patel: Lipid disorders of patients with chronic kidney disease
103: Stephan R. Orth: Smoking in chronic kidney disease
104: Edmund Lamb and Finlay MacKenzie: Analytical aspects of measurements and laboratory values in chronic and acute kidney disease
105: Andrew Williams, Robert Fassett, Erin Howden, and Jeff Coombes: Effect of lifestyle modifications on patients with chronic kidney disease
106: Naveet Kumar, Peter McCulloch, Heather Henderson, and Beverly D. Cameron: Malnutrition, obesity, and undernutrition in chronic kidney disease
107: Carmine Zoccali, Francesca Mallamaci, and Davide Bolignano: Left ventricular hypertrophy in chronic kidney disease
108: Reza Hajhosseini, Kaivan Korvath, and David Goldsmith: Sudden cardiac death in chronic kidney disease
109: Patrick Biggar, Hansjoerg Rothe, and Markus Ketteler: Epidemiology of calcium, phosphate and PTH disturbances in chronic kidney disease
110: Juan Jesus Carrero and Peter Stenvinkel: The role of inflammation in chronic kidney disease
111: John Townend and Charles Ferro: Vascular stiffness in chronic disease - pathophysiology and implications
112: Nostratoli Vaziri: Oxidative stress and its implications in chronic disease
113: Thimoteus Speer and Danilo Fliser: Abnormal endothelial vasomotor and secretory function
114: Neeraj Dhaun and David Webb: Endothelins and their antagonists in chronic kidney disease
115: Stuart Sprague and Menaka Sarav: Chronic kidney disease-mineral and bone disorder: overview
116: Paulo Raggi and Luis D""Marco Gascon: Imaging for detection of vascular disease in chronic kidney disease patients
117: Alexandra Voinescu, Nadia Iqbal and Kevin Martin: Pathophysiology of chronic kidney disease - mineral and bone disorder
118: Alexandra Voinescu, Kevin Martin, Nadia Iqbal, and David Goldsmith: Management of chronic kidney disease - mineral and bone disorder
119: Orlando Gutierrez: Fibroblast growth factor 23, klotho, and phosphorus metabolism in chronic kidney disease
120: Adrian Covic, Mugurel Apetrii, Luminita Voroneanu, and David Goldsmith: Vascular calcification
121: Alastair Hutchison and Michael L. Picton: Fractures in patients with chronic kidney disease
122: Stuart Sprague and James Pullman: Spectrum of bone pathologies in chronic kidney disease
123: Iain Macdougall: Clinical aspects and overview of renal anaemia
124: Iain Macdougall and Jolanta Malyszko: Erythropoiesis-stimulating agents in chronic kidney disease
125: Jolanta Malyszko and Iain Macdougall: Iron metabolism in chronic kidney disease
126: Iain Macdougall: Iron management in renal anaemia
127: Kaivan Khavandi, Halima Amer, Sarah Withers, and Behdad Afzali: Pleoitropic effects of Vitamin D
128: Behdad Afzali and Claudia Kemper: Immunity
129: Fabrizio Fabrizi and Michel Jadoul: The liver and chronic kidney disease
130: Rishi Goel, Kamal Patel, and Terry Wong: Gastroenterology and renal medicine
131: Timur A. Galperin, Kieron S. Leslie, and Antonia J. Cronin: Cutaneous manifestations of end-stage renal disease (ESRD)
132: Tomas Agustsson and Paul Carroll: The patient with reduced renal function: endocrinology
133: Tomas Agustsson and Paul Carroll: Sexual dysfunction
134: Fred Finkelstein and Susan Finkelstein: Health related quality of life and the patient with chronic kidney disease
135: Seema Shrivastava, Beverley Hunt, and Tony Dorling: Coagulopathies in chronic kidney disease
136: Neil Turner: Mechanisms of progression of chronic kidney disese- overview
137: Jeremy Hughes: Proteinuria as a direct cause of progression
138: Valerie Luyckx: Nephron numbers and hyperfiltration as drivers of progression
139: Wilhelm Kriz: Podocyte loss as a common pathway to chronic kidney disease
140: Jeremy Duffield: Disordered scarring and failure of repair
141: Raj Thuraisingham and Cormac Breen: Modality selection for renal replacement therapy
142: Sue Cox and Nicola Thomas: Patient education and involvement in pre-dialysis management
143: Muh Geot Wong, Bruce A. Cooper, and Carol A. Pollock: Preparation for renal replacement therapy
144: Karthik Tennankore and Chris Chan: Choices and considerations for in-centre versus home based renal replacement therapy
145: Aine Burns and Fliss E.M. Murtagh: Conservative care in advanced chronic kidney disease
146: Katie Vinen, Fliss E.M. Murtagh, and Irene Higginson: Palliative care in end stage renal disease
147: Bernadette Thomas and Christopher Blagg: Patient selection when resources are limited
148: Muhammad Magdi Yaqoob: Acidosis in chronic kidney disease
VOLUME 2
Part 6: The patient with another primary diagnosis
149: Luigi Gnudi, Giorgio Gentile, and Piero Ruggenenti: The patient with diabetes mellitus
150: Pierre M. Ronco: Kidney involvement in plasma cell dyscrasias
151: Fabrizio Fabrizi and Patrice Cacoub: The patient with cryoglobulinaemia
152: Helen J. Lachmann and Giampaolo Merlini: The patient with amyloidosis
153: Efstathios Kastritis and M. A. Dimopoulos: The patient with myeloma
154: Dirk R. J. Kuypers and Morie A. Gertz: Light chain deposition disease
155: Fernardo Fervenza, S. Vincent Raj Kumar, and Sethi Sanjeev: Other consequences from monoclonal immunoglobulins/fragments: Membranoproliferative Glomerulonephritis and Acquired Fanconi Syndrome
156: Ravi Rajakaria and Muhammad Magdi Yaqoob: The patient with sarcoidosis
157: David Jayne: The patient with vasculitis- overview
158: Peter Heeringa and Coen A. Stegeman: The patient with vasculitis: pathogenesis
159: Alan Salama: The patient with vasculitis: clinical aspects
160: Lorraine Harper and David Jayne: The patient with vasculitis: treatment and outcome
161: Johan van der Vlag and Jo H.M. Berden: The patient with systemic lupus erythematosus: overview and pathogenesis
162: Marie Condon, Philippa Dodd, and Liz Lightstone: The patient with systemic lupus erythematosus: clinical features, investigations, and diagnosis
163: Frederic Houssiau: The patient with systemic lupus erythematosus: treatment and outcome
164: Bassam Alchi and David Jayne: The patient with antiphospholipid syndrome with or without lupus
165: Aine Burns and Bernadette Lynch: The patient with scleroderma-systemic sclerosis
166: Lesley-Anne Bissell, Dwomoa Adu, and Paul Emery: The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjögren syndrome, or overlap syndrome
167: Jean-Philippe Haymann and François Lionnet: The patient with sickle cell anemia
168: Maarit Korkeila, Bengt Lindholm, and Peter Stenvinkel: The obese patient (metabolic syndrome)
169: Andres Cardenas and Pere Ginès: The patient with hepatorenal syndrome
170: Paul Goodyer: Kidney/ear syndromes
171: Friederike Mackensen, Vedat Schwenger, and Heiko Billing: Kidney/eye syndromes
172: Tim Eisen: The patient with renal cell cancer
173: Christopher D. Mitchell: The patient with Wilms"" tumour
174: Marina Noris and Tim Goodship: The patient with haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura
Part 7: The patient with urinary tract infection
175: Neil Sheerin: Urinary tract infection in the adult: overview
176: Ased Ali and Rob Pickard: Infection of the lower urinary tract
177: Mark Harber: Upper urinary tract infection
178: Ased Ali and Rob Pickard: Complicated urinary tract infection
179: Mark Harber: Urinary tract infection in a patient with a kidney transplant
180: Heather Lambert: Urinary tract infection in infancy and childhood
181: Rashad Barsoum: Schistosomiasis: the parasite and the host
182: Rashad Barsoum: Schistosomiasis: clinical impact
Part 8: The patient with infections causing renal disease
183: Vinay Sakhuja and Harbir Singh Kohli: Malaria
184: Vinay Sakhuja and Harbir Singh Kohli: Leishmaniasis and trypanosomiasis
185: Marion Muche and Seema Baid-Agrawal: Hepatitis B
186: Fabrizio Fabrizi: Hepatitis C
187: Saraladevi Naicker and Graham Paget: HIV and renal disease
188: Hung-Chun Chen and Jan Clement: Hantaviral infections
189: Jung-San Chang and Hung-Chun Chen: Dengue and other viral haemorrhagic fevers
190: Norbert Lameire: Yellow fever, severe acute respiratory syndrome virus, and H1N1 influenza infections
191: Emmanuel A. Burdmann: Leptospirosis
192: Emmanuel A. Burdmann: Syphilis
193: Emmanuel A. Burdmann and Vivekanand Jha: Rickettsiosis
194: Rashad S. Barsoum: Schistosomiasis
195: Raja Ramachandran and Vivekanand Jha: Nematode infections
196: John Eastwood, Catherine M. Corbishley, and John M. Grange: Mycobacterial infections: tuberculosis
197: John Eastwood, Catherine M. Corbishley, and John M. Grange: Mycobacterial infections: leprosy and environmental mycobacteria
198: Raja Ramachandran and Vivekanand Jha: Renal involvement in other infections
Part 9: The patient with urinary stone disease
199: Eric Taylor and Gary Curhan: Epidemiology of nephrolithiasis
200: Bhavna Chopra and Stanley Goldfarb: Approach to the patient with kidney stones
201: David A. Bushinsky and Orson Moe: Calcium stones
202: Michel Daudon and Paul Jungers: Uric acid stones
203: Michel Daudon and Paul Jungers: Cystine stones
204: Benjamin A. Vervaet and Marc E. De Broe: Cell biology of nephrocalcinosis/nephrolithiasis
205: Bridget Sinnott, Naim Maalouf, Khashayar Sakhaee, and Orson W. Moe: Medical management of nephrocalcinosis and nephrolithiasis
206: Gauthier Raynal and Olivier Traxer: Imaging and interventional treatment: urolithiasis from the surgeon>""s point of view
Part 10: The patient with hypertension
207: Karlhans Endlich and Rodger Loutzenhiser: The structure and function of renal blood vessels
08: Karlhans Endlich and Rodger Loutzenhiser: Regulation of vasomotor tone in the afferent and efferent arterioles
209: Karlhans Endlich and Rodger Loutzenhiser: Tubuloglomerular feedback and autoregulation of renal blood flow and glomerular filtration rate
210: O. Gonzalez-Albarrána and Luis M. Ruilopeb: The kidney and control of blood pressure
211: Ulrich Wenzel, Thorsten Wiech, and Udo Helmchen: The effect of hypertension on renal vasculature and structure
212: Helen Alderson, Constantina Chrysochou, James Ritchie, and Philip Kalra: Ischaemic nephropathy
213: James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: clinical features and diagnosis
214: James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: diagnosis
215: James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: management and outcome
216: Caroline Whitworth and Stewart Fleming: Malignant hypertension
217: David Webb and Ian MacIntyre: Resistant hypertension
218: Wolfgang Rascher: The hypertensive child
219: Wolfgang Rascher: Treatment of hypertension in children
Part 11: The patient with acute kidney injury (and critical care nephrology)
220: Eric AJ Hoste and John A. Kellum: Definitions, classification, epidemiology, and risk factors of acute kidney injury
221: Michael S. Goligorsky and Julien Maizel (with contributions by R Vasko, M Rabadi, and B Ratliff): Pathophysiology of acute kidney injury
222: Norbert Lameire, Raymond Vanholder and Wim Van Biesen: Clinical approach to the patient with acute kidney injury: diagnosis and differential diagnosis
223: Norbert Lameire: The role of novel biomarkers in acute kidney injury
224: Norbert Lameire: Prevention of acute kidney injury: overview
225: Norbert Lameire: Prevention of acute kidney injury: non-pharmacological strategies
226: Norbert Lameire: Prevention of acute kidney injury: pharmacological strategies
227: Norbert Lameire: Prevention of acute kidney injury: drug- and nephrotoxin-induced acute kidney injury
228: Achim Jörres, Dietrich Hasper, and Michael Oppert: Non-dialytic management of the patient with acute kidney injury
229: Achim Jörres, Dietrich Hasper, and Michael Oppert: Fluid overload
230: Achim Jörres, Dietrich Hasper, and Michael Oppert: Electrolyte and acid-base disorders
231: Achim Jörres, Dietrich Hasper, and Michael Oppert: Coagulation disturbances
232: Jang Won Seo and Ravindra L. Mehta: Renal replacement therapy in the patient with acute kidney injury: overview
233: Mark R Marshall: Intermittent acute renal replacement therapy
234: Miet Schetz and Andrew Davenport: Continuous renal replacement therapy
235: Wim Van Biesen: Peritoneal dialysis in acute kidney injury
236: Angel Candela, Teresa Tenorio, Aurora Lietor, and Fernando Liaño: Scoring systems in acute kidney injury patients
237: Norbert Lameire, Wim Van Biesen, and Raymond Vanholder: Short and long-term overall outcome and renal prognosis of AKI
238: Norbert Lameire: Overall and renal prognosis of AKI
239: Alexander Fichtner and Franz Schaefer: Acute kidney injury in children
240: Dinna N. Cruz, Anna Clementi, and Mitchell H. Rosner: Acute kidney injury in the elderly
241: Vivekanand Jha: Acute kidney injury in the tropics
242: Jan Clement and Piet Maes: Acute kidney injury and hantavirus disease
243: Norbert Lameire: Community-acquired pneumonia and acute kidney injury
244: John Prowle and Rinaldo Bellomo: Acute kidney injury in severe sepsis
245: Jeremiah R. Brown and Chirag R. Parikh: Cardiovascular surgery and acute kidney injury
246: Douglas Stewart, Gaurav Shah, Jeremiah R. Brown, and Peter A. McCullough: Contrast-induced acute kidney injury
247: Vicente Arroyo, Monica Guevara, and Javier Fernández: Renal failure in cirrhosis: pathogenesis, diagnosis, and treatment
248: Dinna N. Cruz, Anna Giuliani, and Claudio Ronco: Acute kidney injury in heart failure
249: Soo Young Yoon and Ravindra L. Mehta: Acute kidney injury in pulmonary diseases
250: Duska Dragun and Björn Hegner: Acute kidney injury in pregnancy
251: Gilbert W. Moeckel, Veena Manjunath, and Mark A. Perazella: Acute kidney injury in the cancer patient
252: Mehmet Sukru Sever and Raymond Vanholder: Acute kidney injury in polytrauma and rhabdomyolysis
253: Nele Brusselaers and Eric AJ Hoste: Acute kidney injury in patients with severe burn injury
VOLUME 3
Part 12: The patient on dialysis
254: Griet Glorieux, Nathalie Neirynck, Anneleen Pletinck, Eva Schepers, and Raymond Vanholder: Uraemic toxins: overview
255: Jonathan Himmelfarb: Haemodialysis: overview
256: Michael Allon: Haemodialysis: vascular access
257: Claudio Ronco and William R. Clark: Haemodialysis: principles
258: Scott D. Bieber and Jonathan Himmelfarb: Haemodialysis: prescription and assessment of adequacy
259: Victor F. Seabra and Bertrand L. Jaber: Hemodialysis: acute complications
260: Francesco Locatelli, Celestina Manzoni, and Giuseppe Pontoriero: Haemofiltration and haemodiafiltration
261: Arkadiy Pinkhasov, Michael J Germain, and Lewis M. Cohen: Dialysis withdrawal and palliative care
262: Alan S. Kliger and Rita Suri: Frequent haemodialysis
263: Rajnish Mehrotra and Jonathan Himmelfarb: Peritoneal dialysis: overview
264: Joanna Stachowska-Pietka, Jacek Waniewski, and Bengt Lindholm: Peritoneal dialysis: principles and peritoneal physiology
265: Anjali Bhatt Saxena: Peritoneal dialysis: adequacy and prescription management
266: Sara Dunsmore and Joanne Bargman: Peritoneal dialysis: non-infectious complications
267: Allen R. Nissenson, John Moran, and Robert Provenzano: Overview of dialysis patient management and future directions
268: Gerard M. London: Cardiovascular complications in end-stage renal disease patients: pathophysiological aspects
269: Laura Labriola, Michel Jadoul, and Eric Goffin: Bacterial and fungal infections in patients on haemodialysis
270: Laura Labriola, Michel Jadoul, and Eric Goffin: Bacterial and fungal infections in patients on peritoneal dialysis
271: Laura Labriola, Michel Jadoul, and Eric Goffin: Virus infections in patients on dialysis
272: Manjula Kurella Tamura, Mark L. Unruh, and Ea Wha Kang: Cognitive function, depression, and psychosocial adaptation
273: Rajiv Agarwal: Volume assessment and management in dialysis
274: Carla Maria Avesani, Juan Jesús Carrero, Bengt Lindholm, and Peter Stenvinkel: Nutritional screening and nutritional management in dialysis patients
Part 13: The transplant patient
275: Peter J Morris and Jeremy R Chapman: The evolution of kidney transplantation
276: Christophe Legendre: Pre-transplant assessment of the recipient
277: Thomas Mone: Organ donation
278: Richard DM Allen and Henry CC Pleass: Donor and recipient kidney transplantation surgery
279: Thangamani Muthukumar, Darshana Dadhania, Choli Hartono, Manikkam Suthanthiran, and Choli Hartono: Immunology, sensitization, and histocompatibility
280: Simon R Knight and Rutger J Ploeg: Immediate post-transplant care and surgical complications
281: Dirk R J Kuypers and Maarten Naesens: Immunosuppression, drugs, and protocols
282: Simon Gruenewald and Philip Vladica: Renal transplant imaging
283: David N. Rush and Peter W. Nickerson: Rejection
284: Camille Nelson Kotton: Infection: prophylaxis, diagnosis, and management
285: Emily P McQuarrie, Hallvard Holdaas, Bengt Fellström, and Alan G Jardine: Cardiovascular disease: prophylaxis, diagnosis, and management
286: L.K. Henderson, B.J. Nankivell, and J.R. Chapman: Chronic allograft dysfunction
287: Germaine Wong and Angela C Webster: Cancer after kidney transplantation
288: Grahame J Elder: Metabolic bone disease: prophylaxis, diagnosis, and management
289: Philip Clayton and Steven Chadban: Recurrent renal disease: prophylaxis, diagnosis, and management
290: Minnie M. Sarwal and Ron Shapiro: Paediatric renal transplantation
Part 14: Renal disease at different stages of life
291: Lesley Rees: Growth and development
292: Stephen D Marks: The adolescent with renal disease: transition to adult services
293: Kate Wiles and Catherine Nelson-Piercy: Contraception in patients with kidney disease
294: Kate Bramham and Catherine Nelson-Piercy: Pregnancy and renal physiology
295: Kate Bramham and Catherine Nelson-Piercy: Pregnancy in patients with chronic kidney disease and on dialysis
296: Kate Wiles and Catherine Nelson-Piercy: Pre-eclampsia and related disorders
297: Kate Wiles and Catherine Nelson-Piercy: Acute renal disease in pregnancy
298: Kate Bramham and Catherine Nelson-Piercy: Specific renal conditions in pregnancy
299: Kate Bramham and Catherine Nelson-Piercy: Pregnancy after renal transplantation
300: Richard J. Glassock and Andrew D. Rule: The kidney in ageing: biology, anatomy, physiology, and clinical relevance
Part 15: The patient with genetic renal disease
301: Frances Flinter: Ethical aspects of genetic testing
302: Frances Flinter: Antenatal diagnosis and pre-implantation genetic testing
303: Wolfgang Kühn and Gerd Walz: The molecular basis of ciliopathies and cyst formation
304: Yves Pirson and Olivier Devuyst: The adult with renal cysts
305: Carsten Bergmann, N. Ortis-Bruchle, V. Frank, and Klaus Zerres: The child with renal cysts
306: Albert CM Ong and Richard Sandford: Autosomal dominant polycystic kidney disease: overview
307: Albert CM Ong and Timothy Ellam: Autosomal dominant polycystic kidney disease: clinical features
308: Richard Sandford: Autosomal dominant polycystic kidney disease: diagnosis
309: Young-Hwan Hwang and York Pei: Autosomal dominant polycystic kidney disease: management (including strategies to slow progression)
310: Yves Pirson and Dominique Chauveau: Management of intracranial aneurysms
311: Joost Drenth and Tom Gevers: Management of cystic liver disease
312: Carsten Bergmann and Klaus Zerres: Autosomal dominant polycystic kidney disease in children and young adults
313: Carsten Bergmann and Klaus Zerres: Autosomal recessive polycystic kidney disease
314: Lukas Foggensteiner and Philip Beales: Bardet-Biedl syndrome and other ciliopathies
315: Coralie Bingham: Hepatocyte nuclear factor-1B
316: John A Sayer: Nephronophthisis and medullary cystic kidney disease: overview
317: John A Sayer and Roslyn J Simms: Nephronophthisis
318: John A Sayer: Medullary cystic kidney disease and other autosomal dominant inherited interstitial kidney diseases
319: Brunella Franco: Oral-facial-digital type 1 syndrome
320: Rachel Lennon and Neil Turner: The molecular basis of glomerular basement membrane disorders
321: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: overview
322: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: clinical features
323: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: diagnosis
324: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: management
325: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Thin glomerular basement membrane nephropathy and other collagenopathies
326: Laurence Heidet and Marie Claire Gubler: Nail patella syndrome
327: Moin A. Saleem and Corinne Antignac: Molecular basis of nephrotic syndrome
328: Tom Connor and Patrick Maxwell: Molecular basis of renal tumour syndromes
329: Nick Hastie and Eve Miller-Hodges: WT1 and its disorders
330: Bradley P. Dixon, J. Christopher Kingswood, and John J. Bissler: Tuberous sclerosis complex renal disease
331: Tom Connor and Patrick Maxwell: Hypoxia-inducible factor and renal disorders
332: Tom Connor and Patrick Maxwell: Von Hippel-Lindau disease
333: Nicholas Medjeral-Thomas, Anna Richards, and Matthew C. Pickering: Molecular basis of complement-mediated renal disease
334: Robin Lachmann and Elaine Murphy: Inherited metabolic diseases and the kidney
335: Stephen Waldek: Fabry disease: overview and pathophysiology
336: Stephen Waldek: Fabry disease: clinical features
337: Stephen Waldek: Fabry disease: diagnosis
338: Stephen Waldek: Fabry disease: management and outcome
339: Elena N. Levtchenko and Mirian C. Janssen: Cystinosis
340: Andrew Hall and Shamima Rahman: Mitochondrial diseases and the kidney
341: Neil Turner, Teena Tandon, and Rajiv Agarwal: APOL1 and renal disease
342: Neil Turner and Bertrand Knebelmann: MYH9 and renal disease
Part 16: The patient with structural and congenital abnormalities
343: Paul Winyard: Human kidney development
344: Oren Pleniceanu and Benjamin Dekel: Kidney stem cells
345: Michiel Schreuder: Anatomical types of congenital anomalies: overview of obstruction
346: Michiel Schreuder: Renal agenesis
347: Michiel Schreuder: Renal dysplasia
348: Michiel Schreuder: Renal hypoplasia
349: Michiel Schreuder: Normal variation in nephron numbers
350: Michiel Schreuder: Renal tubular dysgenesis
351: Michiel Schreuder: Congenital solitary functioning kidney
352: Michiel Schreuder: Duplex, ectopic, and horseshoe kidneys
353: Michiel Schreuder: Pelviureteric junction obstruction and megaureter
354: Michiel Schreuder: Posterior urethral valves
355: Heather Lambert: Vesicoureteric reflux and reflux nephropathy
356: Muhammad M. Yaqoob, Katherine Bennett-Richards, and Islam Junaid: The patient with urinary tract obstruction
357: Muhammad M. Yaqoob, Katherine Bennett-Richards, and Islam Junaid: Retroperitoneal fibrosis
358: Udo Vester and Stefanie Weber: Branchio-oto-renal syndrome
359: Udo Vester and Stefanie Weber: Townes-Brocks syndrome
360: Udo Vester and Stefanie Weber: Renal coloboma syndrome
361: Fred E. Avni, Marie Cassart, Anne Massez, and Michèle Hall: Ante- and postnatal imaging to diagnose human kidney malformations
Part 17: Drugs and renal disease
362: Anushree Shirali and Mark A. Perazella: Drug-induced nephropathies
363: Ali J. Olyaei, Ted A. Foster, and Edgar V. Lerma: Drug dosing in chronic kidney disease
364: Thomas A. Golper, Andrew A. Udy, and Jeffrey Lipman: Drug dosing in acute kidney injury